Inventor · Wellesley, MA, US

Henryk T. Dudek

59Patents
6h-index
25Co-inventors
72Inventor score

Filing activity: Oct 14, 1999 → Aug 16, 2024

Most-cited inventions

PatentTitleAreaCited byStatus
US6291516A Regulators of the hedgehog pathway, compositions and uses related thereto Human Necessities 57 Expired
US6686388B2 Regulators of the hedgehog pathway, compositions and uses related thereto Human Necessities 31 Expired
US8357368B2 Methods of treating pancreatic or liver cancer using hedgehog antagonists Chemistry; Metallurgy 22 Active
US9458457B2 Methods and compositions for the specific inhibition of alpha-1 antitrypsin by double-stranded RNA Chemistry; Metallurgy 16 Active
US10370655B2 Methods and compositions for the specific inhibition of alpha-1 antitrypsin by double-stranded RNA Chemistry; Metallurgy 13 Active
US9701966B2 Methods and compositions for the specific inhibition of glycolate oxidase (HAO1) by double-stranded RNA Chemistry; Metallurgy 11 Active
US8815825B2 Methods and compositions for the specific inhibition of beta-catenin by double-stranded RNA Chemistry; Metallurgy 6 Active
US7708998B2 Methods of inhibiting unwanted cell proliferation using hedgehog antagonists Chemistry; Metallurgy 6 Expired
US10150965B2 Methods and compositions for the specific inhibition of transthyretin (TTR) by double-stranded RNA Chemistry; Metallurgy 5 Active
US8927515B2 Methods and compositions for the specific inhibition of androgen receptor by double-stranded RNA Chemistry; Metallurgy 5 Active
US10351854B2 Therapeutic inhibition of lactate dehydrogenase and agents therefor Emerging Cross-Sectional Technologies 5 Active
US9828606B2 Methods and compositions for the specific inhibition of glycolate oxidase (HAO1) by double-stranded RNA Chemistry; Metallurgy 5 Active
US9732347B2 Methods and compositions for the specific inhibition of androgen receptor by double-stranded RNA Chemistry; Metallurgy 4 Active
US10036017B2 Methods and compositions for the specific inhibition of complement component 5(C5) by double-stranded RNA Chemistry; Metallurgy 3 Active
US10738311B2 Therapeutic inhibition of lactate dehydrogenase and agents therefor Emerging Cross-Sectional Technologies 3 Active
US8486400B2 Methods of inhibiting unwanted cell proliferation using an antibody that binds to sonic hedgehog and inhibits hedgehog signaling Chemistry; Metallurgy 3 Active
US11053502B1 Therapeutic inhibition of lactate dehydrogenase and agents therefor Emerging Cross-Sectional Technologies 2 Active
US10435692B2 Methods and compositions for the specific inhibition of glycolate oxidase (HAO1) by double-stranded RNA Chemistry; Metallurgy 2 Active
US10487330B2 Methods and compositions for the specific inhibition of glycolate oxidase (HAO1) by double-stranded RNA Chemistry; Metallurgy 2 Active
US10465195B2 Methods and compositions for the specific inhibition of glycolate oxidase (HAO1) by double-stranded RNA Chemistry; Metallurgy 2 Active
US9243244B2 Methods and compositions for the specific inhibition of beta-catenin by double stranded RNA Chemistry; Metallurgy 1 Active
US10072263B2 Methods and compositions for the specific inhibition of beta-catenin by double-stranded RNA Chemistry; Metallurgy 1 Active
US10676742B2 Methods and compositions for the specific inhibition of transthyretin (TTR) by double-stranded RNA Chemistry; Metallurgy 1 Active
US11566248B2 PCSK9 targeting oligonucleotides for treating hypercholesterolemia and related conditions Chemistry; Metallurgy 1 Active
US9708605B2 Methods and compositions for the specific inhibition of MCL1 by double-stranded RNA Chemistry; Metallurgy 1 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.